The approval is based on a nearly five-year-long study in which once-weekly injections of Wegovy were shown to reduce the overall risk of major adverse cardiac eventsincluding stroke, heart attack, and deathby 20% compared to a placebo.
While the desire to lose weight may be seen by some as mere vanity, it is hard to argue against covering the cost of a drug that significantly cuts the risk of heart attack, stroke, and premature death.
[
add
]
[
|
|
...
]